The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
Open accessAbstract
CD39/ENTPD1 hydrolyzes proinflammatory nucleotides to generate adenosine. As purinergic mediators have been implicated in intestinal inflammation, we hypothesized that CD39 might protect against inflammatory bowel disease. We studied these possibilities in a mouse model of colitis using mice with global CD39 deletion. We then tested whether human genetic polymorphisms in the CD39 gene might influence susceptibility to Crohn's disease. We induced colitis in mice using Dextran Sodium Sulfate (DSS). Readouts included disease activity scores, histological evidence of injury, and markers of inflammatory activity. We used HapMap cell lines to find SNPs that tag for CD39 expression, and then compared the frequency of subjects with high vs. low CD39-expression genotypes in a case-control cohort for Crohn's disease. Mice null for CD39 were highly susceptible to DSS injury, with heterozygote mice showing an intermediate phenotype compared to wild type (WT). We identified a common SNP that tags CD39 mRNA expression levels in man. The SNP tagging low levels of CD39 expression was associated with increased susceptibility to Crohn's disease in a case-control cohort comprised of 1,748 Crohn's patients and 2,936 controls ( P = 0.005–0.0006). Our data indicate that CD39 deficiency exacerbates murine colitis and suggest that CD39 polymorphisms are associated with inflammatory bowel disease in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with these in vitro observations, individuals with reduced ability to transcribe CD39 due to a promoter polymorphism (Friedman et al., 2009) have better responses to TIV as well as VZV vaccination”
From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Friedman et al., 2009
In the citing paper
“In humans, polymorphisms of ENTPD1 were shown to be associated with IBD, and expression of P2X7 was increased in the intestinal epithelium and lamina propria of IBD patients (Friedman et al., 2009; Neves et al., 2014).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Friedman et al., 2009
In the citing paper
“Entpd1−/− mice, which cannot remove extracellular ATP through this mechanism, where highly susceptible to experimental colitis (Friedman et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Friedman et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
Self-citationPopulation genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,153
ATP drives lamina propria TH17 cell differentiation
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., et al. (2008) · Nature · doi:10.1038/nature07240 · Cited by 1,089
A genome-wide association study of global gene expression
Dixon, A. L., Liang, L., Moffatt, M. F., Chen, W., Heath, S. C., Wong, K., Taylor, J. C., Burnett, E. C., Gut, I. G., Farrall, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2109 · Cited by 946
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940
Robson, S. C., Sévigny, J., & Zimmermann, H. (2006) · Purinergic Signalling · doi:10.1007/s11302-006-9003-5 · Cited by 930
Self-citationTysk, C., Lindberg, E. H., Järnerot, G., & FLODERUS-MYRHED, B. (1988) · Gut · doi:10.1136/gut.29.7.990 · Cited by 828
Flagged first, then by citations
Research works printed but not linked: 1
- 10.2337/db07-1265 · DOI
Cited by
Sorted by citations
Items 101–200 of 284
The Inflammatory Tissue Microenvironment in IBD
Colgan, S. P., Curtis, V. F., & Campbell, E. L. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcaaf · Cited by 52
Peri, L. E., Sanders, K. M., & Mutafova–Yambolieva, V. N. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12174 · Cited by 53
Genetic variation in P2RX7 and pain tolerance
Kambur, O., Kaunisto, M. A., Winsvold, B. S., Wilsgaard, T., Stubhaug, A., Zwart, J., Kalso, E. A., & Nielsen, C. S. (2018) · Pain · doi:10.1097/j.pain.0000000000001188 · Cited by 49
ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis
da Silva, J. L. G., Passos, D. F., Bernardes, V. M., & Leal, D. B. R. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.009 · Cited by 51
Sitkovsky, M. V., & Ohta, A. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1001-9 · Cited by 51
Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection
Tang, Y., Li, J., Zheng, Y., Ni, B., & Wu, Y. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-17 · Cited by 49
Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism
Nagahama, Y., Shimoda, M., Mao, G., Singh, S. K., Kozakai, Y., Sun, X., Motooka, D., Nakamura, S., Tanaka, H., Satoh, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809575115 · Cited by 49
Ectonucleotidases in Intestinal and Hepatic Inflammation
Vuerich, M., Robson, S. C., & Longhi, M. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00507 · Cited by 48
Self-citationEctonucleotidases in Inflammation, Immunity, and Cancer
Haas, C. B., Lovászi, M., Braganhol, E., Pacher, P., & Haskó, G. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001342 · Cited by 51
Gut Microbiota, Probiotics and Inflammatory Bowel Disease
Stephani, J., Radulovic, K., & Niess, J. H. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0122-5 · Cited by 50
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice
Covarrubias, R., Chepurko, E., Reynolds, A., Huttinger, Z. M., Huttinger, R. M., Stanfill, K. E., Wheeler, D. G., Novitskaya, T., Robson, S. C., Dwyer, K. M., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307374 · Cited by 47
Self-citationImplications of CD39 in immune-related diseases
Zeng, J., Ning, Z., Zhang, H., Dong, G., Zhang, J., Shi, H., Yan, F., Zhao, M., Wang, C., Ma, Q., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107055 · Cited by 46
Alam, M. S., Costales, M. G., Cavanaugh, C., & Williams, K. M. (2015) · Biomolecules · doi:10.3390/biom5020775 · Cited by 45
The TGF‐b/SOX4 axis and ROS‐driven autophagy co‐mediate CD39 expression in regulatory T‐cells
Gerner, M. C., Ziegler, L. S., Schmidt, R. L. J., Krenn, M., Zimprich, F., Uyanik‐Ünal, K., Konstantopoulou, V., Derdak, S. V., Favero, G. D., Schwarzinger, I., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902664 · Cited by 45
Gelderblom, M., Sobey, C. G., Kleinschnitz, C., & Magnus, T. U. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.004 · Cited by 44
Kurashima, Y., & Kiyono, H. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.7 · Cited by 42
Interface between hemostasis and adaptive immunity
Qu, Z., & Chaikof, E. L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.017 · Cited by 43
Genetically driven CD39 expression shapes human tumor‐infiltrating CD8 + T‐cell functions
Gallerano, D., Ciminati, S., Grimaldi, A., Piconese, S., Cammarata, I., Focaccetti, C., Pacella, I., Accapezzato, D., Lancellotti, F., Sacco, L., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33131 · Cited by 43
Grubišić, V., Bali, V., Fried, D. E., Eltzschig, H. K., Robson, S. C., Mazei‐Robison, M. S., & Gulbransen, B. D. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00550-7 · Cited by 40
Self-citationCD73 Plays a Protective Role in Collagen-Induced Arthritis
Chrobák, P., Charlebois, R., Rejtar, P., Bikai, R. E., Allard, B., & Stagg, J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401416 · Cited by 40
ATP as a Pathophysiologic Mediator of Bacteria-Host Crosstalk in the Gastrointestinal Tract
Inami, A., Kiyono, H., & Kurashima, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082371 · Cited by 40
Control of Gut Inflammation by Modulation of Purinergic Signaling
Vuerich, M., Mukherjee, S., Robson, S. C., & Longhi, M. S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01882 · Cited by 39
Self-citationMelchiotti, R., Puan, K. J., Andiappan, A. K., Poh, T. Y., Starke, M., Li, Z., Petsch, K., Lai, T. S., Chew, F. T., Larbi, A., et al. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-73 · Cited by 38
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease
Apostolova, P., & Zeiser, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00439 · Cited by 38
Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation.
Cao, W.-Q., Fang, F., Gould, T. M., Li, X., Kim, C., Gustafson, C., Lambert, S., Weyand, C., & Goronzy, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132417 · Cited by 34
Gupta, V., Katiyar, S., Singh, A., Misra, R., & Aggarwal, A. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13333 · Cited by 37
Genç, B., Gözütok, Ö., & Özdi̇nler, P. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163848 · Cited by 36
Purinergic Signaling in Liver Disease
Vaughn, B. P., Robson, S. C., & Longhi, M. S. (2014) · Digestive Diseases · doi:10.1159/000360498 · Cited by 34
Self-citationThe roles of purinergic signaling during gastrointestinal inflammation
Roberts, J. A., Lukewich, M. K., Sharkey, K. A., Furness, J. B., Mawe, G. M., & Lomax, A. E. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.011 · Cited by 34
Hazenberg, M. D., Haverkate, N. J. E., van Lier, Y. F., Spits, H., Krabbendam, L., Bemelman, W. A., Buskens, C. J., Blom, B., & Shikhagaie, M. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000176 · Cited by 34
Francois, V., Shehade, H., Acolty, V., Preyat, N., Delrée, P., Moser, M., & Oldenhove, G. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.108 · Cited by 34
Potenza, A., Balestrieri, C., Spiga, M., Albarello, L., Pedica, F., Manfredi, F., Cianciotti, B. C., de Lalla, C., Botrugno, O. A., Faccani, C., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328042 · Cited by 33
Weinhage, T., Däbritz, J., Brockhausen, A., Wirth, T., Brückner, M., Belz, M., Foell, D., & Varga, G. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.04.005 · Cited by 33
Jiang, Z. G., Wu, Y., Csizmadia, E., Feldbrügge, L., Enjyoji, K., Tigges, J., Toxavidis, V., Stephan, H., Müller, C. E., McKnight, C. J., et al. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9423-6 · Cited by 33
Self-citationAdenosine in Intestinal Epithelial Barrier Function
Stepanova, M., & Aherne, C. M. (2024) · Cells · doi:10.3390/cells13050381 · Cited by 34
Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction
Knight, J. S., Mazza, L. F., Yalavarthi, S., Sule, G. J., Ali, R. A., Hodgin, J. B., Kanthi, Y. M., & Pinsky, D. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01322 · Cited by 32
Zhu, Y., Zhou, M., Cheng, X., Wang, H., Li, Y., Guo, Y., Wang, Y., Tian, S., Mao, T., Zhang, Z., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00210 · Cited by 31
Adenosine modulates Toll-like receptor function: basic mechanisms and translational opportunities
Coombs, M. R. P., Belderbos, M. E., Gallington, L. C., Bont, L., & Levy, O. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.158 · Cited by 31
Aryl hydrocarbon receptor controls regulatory CD4+T cell function
Pot, C. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13592 · Cited by 33
Grubišić, V., Perez-Medina, A. L., Fried, D. E., Sévigny, J., Robson, S. C., Galligan, J. J., & Gulbransen, B. D. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00104.2019 · Cited by 31
Self-citationEndogenous antisense RNA curbs CD39 expression in Crohn’s disease
Harshe, R. P., Xie, A., Vuerich, M., Frank, L. A., Gromová, B., Zhang, H., Robles, R. J., Mukherjee, S., Csizmadia, E., Kokkotou, E. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19692-y · Cited by 31
Self-citationTissue metabolism and the inflammatory bowel diseases
Lanis, J. M., Kao, D. J., Alexeev, E. E., & Colgan, S. P. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1544-2 · Cited by 30
Timperi, E., Folgori, L., Amodio, D., Luca, M. D., Chiurchiù, S., Piconese, S., Cesare, S. D., Pacella, I., Martire, C., Bonatti, G., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.048 · Cited by 30
Variable Impact of CD39 in Experimental Murine Colitis
Künzli, B. M., Berberat, P. O., Dwyer, K. M., Deaglio, S., Csizmadia, E., Cowan, P. J., d’Apice, A. J. F., Moore, G. T., Enjyoji, K., Frieß, H., et al. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1425-9 · Cited by 30
Self-citationNTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
Lázár, Z., Müllner, N., Lucattelli, M., Ayata, C. K., Cicko, S., Yegutkin, G. G., Cunto, G. D., Müller, T., Meyer, A., Hoßfeld, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.02144-2014 · Cited by 30
Self-citationPhragmites rhizoma polysaccharide-based nanocarriers for synergistic treatment of ulcerative colitis
Cui, M., Fang, Z., Song, M., Zhou, T., Wang, Y., & Liu, K. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.245 · Cited by 29
Huttinger, Z. M., Milks, M. W., Nickoli, M. S., Aurand, W. L., Long, L. C., Wheeler, D. G., Dwyer, K. M., d’Apice, A. J. F., Robson, S. C., Cowan, P. J., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.024 · Cited by 29
Self-citationMondal, S., Das, M., Ghosh, R., Singh, M., Adhikari, A., Darbar, S., Das, A. K., Bhattacharya, S. S., Pal, D., Bhattacharyya, D., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05023-6 · Cited by 28
Schneider, M., Harnoss, J. M., Strowitzki, M. J., Radhakrishnan, P., Platzer, L. K., Harnoss, J. C., Hank, T. P., Cai, J., & Ulrich, A. B. (2015) · Hypoxia · doi:10.2147/hp.s60872 · Cited by 26
Thrombo-Inflammation: A Focus on NTPDase1/CD39
Morello, S., Caiazzo, E., Turiello, R., & Cicala, C. (2021) · Cells · doi:10.3390/cells10092223 · Cited by 27
Exhaustion of CD39-Expressing CD8+ T Cells in Crohn’s Disease Is Linked to Clinical Outcome
Globig, A.-M., Mayer, L., Heeg, M., Andrieux, G., Ku, M., Otto-Mora, P., Hipp, A. V., Zoldan, K., Pattekar, A., Rana, N., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.045 · Cited by 30
Feldbrügge, L., Moss, A. C., Yee, E. U., Csizmadia, E., Mitsuhashi, S., Longhi, M. S., Sandhu, B., Stephan, H., Wu, Y., Cheifetz, A. S., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx058 · Cited by 27
Self-citationInhibition of Platelet Function by the Endothelium
Beaulieu, L. M., & Freedman, J. E. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00017-1 · Cited by 26
HO-1 and CD39: It Takes Two to Protect the Realm
Lee, G. R., Shaefi, S., & Otterbein, L. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01765 · Cited by 24
Libera, J., Wittner, M., Kantowski, M., Woost, R., Eberhard, J. M., de Heer, J., Reher, D., Huber, S., Haag, F., & Wiesch, J. S. Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.567472 · Cited by 24
Figliuolo, V. R., Jamwal, D. R., & Kiela, P. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_9 · Cited by 28
Purinergic receptors modulators: An emerging pharmacological tool for disease management
Mahmood, A., & Iqbal, J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21888 · Cited by 24
Attenuated allergic airway inflammation in Cd39 null mice
Idzko, M., Ayata, C. K., Müller, T., Dürk, T., Grimm, M., Baudiß, K., Vieira, R. P., Cicko, S., Boehlke, C. S., Zech, A., et al. (2013) · Allergy · doi:10.1111/all.12119 · Cited by 24
Self-citationDegauque, N., Brosseau, C., & Brouard, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01465 · Cited by 23
Robles, R. J., Mukherjee, S., Vuerich, M., Xie, A., Harshe, R. P., Cowan, P. J., Csizmadia, E., Wu, Y., Moss, A. C., Chen, R., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz182 · Cited by 23
Self-citationXie, X., Zheng, L.-X., Duan, H., Liu, Y., Chen, X., & Cheong, K. (2021) · Food & Function · doi:10.1039/d1fo01201k · Cited by 23
Adenosine in the Inflamed Gut: A Janus Faced Compound
Estrela, A. B., & Abraham, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796011274 · Cited by 23
Li, P., Cao, J., Chen, Y., Wang, W., & Yang, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1771 · Cited by 23
The platelet P2 receptors in inflammation
Cattaneo, M. (2015) · Hämostaseologie · doi:10.5482/hamo-14-09-0044 · Cited by 23
Yao, Y. F., Levings, M. K., & Steiner, T. S. (2012) · European Journal of Immunology · doi:10.1002/eji.201142213 · Cited by 22
Kurashima, Y., Kiyono, H., & Kunisawa, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/427125 · Cited by 23
Shawki, A., Ramirez, R., Spalinger, M. R., Ruegger, P. M., Sayoc-Becerra, A., Santos, A. N., Chatterjee, P., Canale, V., Mitchell, J., Macbeth, J. C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1775538 · Cited by 26
Liu, G.-H., Zhuo, X.-C., Huang, Y.-H., Liu, H.-M., Wu, R., Kuo, C., Chen, N., Chuang, L., Lin, S., Chen, Y., et al. (2022) · Biology · doi:10.3390/biology11070962 · Cited by 21
Extracellular adenosine regulates colitis through effects on lymphoid and nonlymphoid cells
Kurtz, C. C., Drygiannakis, I., Naganuma, M., Feldman, S. H., Bekiaris, V., Linden, J. M., Ware, C. F., & Ernst, P. B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00404.2013 · Cited by 21
Pandolfi, J., Ferraro, A., Lerner, M., Serrano, J., Dueck, A., Fainboim, L., & Arruvito, L. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1214-626r · Cited by 21
Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture
Sutton, N. R., Hayasaki, T., Hyman, M. C., Anyanwu, A. C., Liao, H., Petrovic‐Djergovic, D., Badri, L., Baek, A. E., Walker, N., Fukase, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89504 · Cited by 26
Gulbransen, B. D. (2014) · Colloquium Series on Neuroglia in Biology and Medicine From Physiology to Disease · doi:10.4199/c00113ed1v01y201407ngl002 · Cited by 23
Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease
Vuerich, M., Wang, N., Graham, J. J., Gao, L., Zhang, W., Kalbasi, A., Zhang, L., Csizmadia, E., Hristopoulos, J., Ma, Y., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03913-9 · Cited by 20
Self-citationDysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity
Vuerich, M., Harshe, R. P., Robson, S. C., & Longhi, M. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030528 · Cited by 20
Self-citationLu, Y., Cheng, L., Li, F., Ji, L., Shao, X., Wu, B., Zhan, Y., Liu, C., Min, Z., Yang, K., et al. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03716-9 · Cited by 20
Adamkova, P., Hradická, P., Skalníková, H. K., Cizkova, V., Vodička, P., Iannaccone, S. F., Kassayová, M., Gancarčíková, S., & Demečková, V. (2022) · Veterinary Sciences · doi:10.3390/vetsci9050238 · Cited by 19
Alternative adenosine Receptor activation: The netrin-Adora2b link
Yuan, X., Mills, T., Doursout, M., Evans, S. E., Melo, M. F. V., & Eltzschig, H. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944994 · Cited by 21
E-NPP3 controls plasmacytoid dendritic cell numbers in the small intestine
Furuta, Y., Tsai, S.-H., Kinoshita, M., Fujimoto, K., Okumura, R., Umemoto, E., Kurashima, Y., Kiyono, H., Kayama, H., & Takeda, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172509 · Cited by 19
Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats
Ercan, G., Yiğittürk, G., & Erbaş, O. (2019) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020190120000004 · Cited by 19
Inflammatory Bowel Diseases: It's Time for the Adenosine System
Antonioli, L., Fornai, M., Pellegrini, C., Bertani, L., Németh, Z. H., & Blandizzi, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01310 · Cited by 19
Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation
Wang, Z., Vaughan, T. Y., Zhu, W., Chen, Y., Fu, G., Medrzycki, M., Nishio, H., Bunting, S. T., Hankey-Giblin, P. A., Nusrat, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00486 · Cited by 18
Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19
Wang, N., Vuerich, M., Kalbasi, A., Graham, J. J., Csizmadia, E., Manickas-Hill, Z., Woolley, A. E., David, C. N., Miller, E. M., Gorman, K. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103205 · Cited by 18
Self-citationZheng, J., Jiang, Z., Song, Y., Huang, S., Du, Y., Yang, X., Xiao, Y., Ma, Z., Xu, D., & Li, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.866228 · Cited by 18
Wang, X., Su, L., Jinhua, T., Ding, T., & Yue, Y. (2023) · PubMed Central · doi:10.22038/ijbms.2022.66678.14624 · Cited by 18
McRae, J. L., Chia, J. S., Pommey, S., & Dwyer, K. M. (2016) · Nephrology · doi:10.1111/nep.12894 · Cited by 18
Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
Altered Ca2+ Homeostasis in Immune Cells during Aging: Role of Ion Channels
Zöphel, D., Hof, C., & Lis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010110 · Cited by 17
Nardi‐Schreiber, A., Sapir, G., Gamliel, A., Kakhlon, O., Sosna, J., Gomori, J. M., Meiner, V., Lossos, A., & Katz‐Brull, R. (2017) · Chemical Communications · doi:10.1039/c7cc00426e · Cited by 17
Friend or Foe – Tc17 cell generation and current evidence for their importance in human disease
Hipp, A. V., Bengsch, B., & Globig, A.-M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad010 · Cited by 18
MUC17 is an essential small intestinal glycocalyx component that is disrupted in Crohn’s disease
Layunta, E., Jäverfelt, S., van de Koolwijk, F. C., Sivertsson, M., Dolan, B., Arike, L., Thulin, S., Vallance, B. A., & Pelaseyed, T. (2024) · JCI Insight · doi:10.1172/jci.insight.181481 · Cited by 15
Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells
Tsai, S. H., & Takeda, K. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0564-2 · Cited by 17
Bae, U., Jang, H., Lee, S. H., Kim, J.-Y., & Kim, G.-C. (2022) · Antioxidants · doi:10.3390/antiox11122429 · Cited by 16
Adenosine receptor activation in the Th17 autoimmune responses of experimental autoimmune uveitis
Li, X., Liang, D., Shao, H., Born, W. K., Kaplan, H. J., & Sun, D. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.09.004 · Cited by 16
IL-4 prevents adenosine-mediated immunoregulation by inhibiting CD39 expression
Fang, F., Cao, W., Mu, Y., Okuyama, H., Li, L., Qiu, J., Weyand, C. M., & Goronzy, J. J. (2022) · JCI Insight · doi:10.1172/jci.insight.157509 · Cited by 15
Li, P., Yang, Q.-Z., Wang, W., Zhang, G., & Yang, J. (2017) · Journal of Asthma · doi:10.1080/02770903.2017.1310225 · Cited by 15
Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver
Savio, L. E. B., Robson, S. C., & Longhi, M. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.621760 · Cited by 15
Self-citationDysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis
Xu, W., Golovchenko, N. B., Martínez-Vargas, I. U., Fong, A., Rout, P., Achi, S. C., Bucar, E. B., Hsieh, J. J., Vidmar, K. J., Zhang, L., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adk7429 · Cited by 15
Purinergic Control of Neutrophil Activation
Grassi, F. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq014 · Cited by 14
Metabolites: deciphering the molecular language between DCs and their environment
Minarrieta, L., Ghorbani, P., Sparwasser, T. D., & Berod, L. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0609-6 · Cited by 15
Pharmacology of Adenosine Receptors and Their Signaling Role in Immunity and Inflammation
Lapa, F. D. R., Macedo-Júnior, S. J., Cerutti, M. L., & Santos, A. R. S. (2014) · InTech eBooks · doi:10.5772/57206 · Cited by 14
Metadata
- Authors
- Friedman, D. J., Künzli, B. M., A-Rahim, Y. I., Sevigny, J., Berberat, P. O., Enjyoji, K., Csizmadia, E., Friess, H., & Robson, S. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Hawaiʻi at Mānoa (US)
- Transplantation Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard University, 330 Brookline Avenue, Boston, MA 02215;
- Technical University of Munich (DE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16788-16793
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2757811
- OpenAlex
- W2163178183
- Cited by
- 284
- References
- 40
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 15 · 2020: 25 · 2019: 23 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 15 · 2012: 21
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Wellcome Trust
- National Institutes of Health (5p01hl076540-10)
- National Heart, Lung, and Blood Institute (HL-57307, HL63972, HL 076540, R01HL094400, P01 HL-076540, R01HL057307, R01HL063972)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK076868)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- CD39, adenosine, purinergic signaling, inflammatory bowel disease, Crohn's disease, colitis, DSS-induced colitis, genetic polymorphism, single nucleotide polymorphisms, genetic susceptibility, nucleotide hydrolysis
- MeSH terms
- Animals, Apyrase, Colitis, Crohn Disease, Disease Models, Animal, Genotype, Humans, Mice, Inbred C57BL, Polymorphism, Genetic, RNA, Messenger, Inflammatory Bowel Diseases, Antigens, CD, Sequence Deletion, Genetic Predisposition to Disease, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
